Donation Programs:
Pfizer Inc.

About Pfizer Inc.

Originally established in 1849 in New York, Pfizer is poised to become the world's largest pharmaceutical company with its upcoming merger of Pharmacia. Currently, the company has more than 90,000 employees working in 60 countries.

The company's mission statement is "We will become the world's most valued company to patients, customers, colleagues, investors, business partners, and the communities where we work and live".

Corporate Giving

Pfizer participates in programs to expand access to medicines on a national and international level. In the US, Pfizer provides medicines at a reduced cost or for free to individuals who are without insurance. The company has recently signed the Global Sullivan Principles for Corporate Social Responsibility as well as the International Chamber of Commerce Business Charter for Sustainable Development.

In 1953, Pfizer has established The Pfizer Foundation, Inc. as an independent charitable foundation. The Foundation's mission is to promote access to quality health care and education, to nurture innovation and to support the community involvement of Pfizer people. The company and foundation have programs operating in every state.

International Essential Medicine Donation Programs

Pfizer is involved with two major private-public partnerships for the improvement of global health through access to essential medicines: The International Trachoma Initiative and the Diflucan Partnership Program.
The International Trachoma Initiative (ITI) is dedicated to the elimination of blinding trachoma, the world's leading cause of preventable blindness. The organization was founded in 1998 by the Edna McConnell Clark Foundation and Pfizer. The ITI seeks to achieve global elimination of blinding trachoma by putting into action the SAFE strategy, including donated Zithromax, applied research and program evaluation, and communications and advocacy.

According to the organization's website:

"Pfizer's Zithromax (azithromycin) donation is a central element of the ITI's support for the SAFE strategy. Zithromax has been proven to be more effective and easier to administer than the previously recommended regimen of tetracycline eye ointment twice daily for six weeks. The result is improved compliance rates and vastly enhanced trachoma control.

Working on an independent basis, the ITI forms partnerships among international agencies and governmental and nongovernmental organizations. The ITI builds on growing international momentum to support the World Health Organization's goal of eliminating this leading cause of preventable blindness by 2020, and maintains the highest scientific and management standards in the pursuit of its mission."

To learn more about this partnership, please visit the website at www.trachoma.org.

Pfizer is also a participant in the Diflucan Partnership Program. The Diflucan Partnership was developed in cooperation with the United Nations and the World Health Organization and expands upon the existing South African Diflucan Partnership Program, a collaboration between Pfizer and the South African Ministry of Health. Pfizer's medication, Diflucan, is not a treatment for HIV/AIDS; however, it has proven highly effective in treating two opportunistic infections, cryptococcal meningitis and esophageal candidiasis, that afflict large numbers of people with AIDS.

Pfizer Inc has stated that it will offer Diflucan® antifungal medicine at no charge to HIV/AIDS patients in 50 least-developed countries as identified by the United Nations where HIV/AIDS is most prevalent.

For more information about this partnership, please visit here

Please visit the Pfizer web site at www.pfizer.com to learn more about the company and its private-public partnerships to improve global health.

<< Return to Donation Programs Main Page